Beetroot (甜菜 tián cài) juice consumption is of current interest for improving aerobic performance by acting as a vasodilator and possibly through alterations in skeletal muscle metabolism and physiology. This work explored the effects of a commercially available beetroot supplement on metabolism, gene expression, and mitochondrial content in cultured myocytes. C2C12 myocytes were treated with various concentrations of the beetroot supplement for various durations. Glycolytic metabolism and oxidative metabolism were quantified via measurement of extracellular acidification and oxygen consumption, respectively. Metabolic gene expression was measured using quantitative reverse transcription-polymerase chain reaction, and mitochondrial content was assessed with flow cytometry and confocal microscopy. Cells treated with beetroot exhibited significantly increased oxidative metabolism, concurrently with elevated metabolic gene expression including peroxisome proliferatoractivated receptor gamma coactivator1 alpha, nuclear respiratory factor 1, mitochondrial transcription factor A, and glucose transporter 4, leading to increased mitochondrial biogenesis. Our data show that treatment with a beetroot supplement increases basal oxidative metabolism. Our observations are also among the first to demonstrate that beetroot extract is an inducer of metabolic gene expression and mitochondrial biogenesis. These observations support the need for further investigation into the therapeutic and pharmacological effects of nitratecontaining supplements for health and athletic benefits.
Introduction
Dietary sources of nitrate are found in a variety of foods including roots and green leafy vegetables, and more recently, some cured/processed meats. Dietary sources of nitrate have become of interest for ergogenic and metabolic purposes because of the ability of dietary nitrate to increase nitric oxide (NO) biosynthesis. Nitrate consumption results in heighted plasma nitrite, which has been previously recognized as an in vivo biomarker of NO production.
Consumption of nitraterich foods prior to endurance events including cycling, rowing, and running results in improved performance, resulting in increasing popularity of nitratecontaining foods.
As a result, commercially available dietary products high in nitrate content have emerged as ergogenic aids purported to increase athletic performance.
NO is a potent cellular stimulus capable of increasing intracellular Ca and cyclic guanosine monophosphate (cGMP) leading to activation of Ca /calmodulindependent protein kinase and 5′ adenosine monophosphateactivated protein kinase (AMPK). Dietary NO precursors including arginine and argininelike metabolites increase NO, stimulating phosphorylation and activation of AMPK, which later acts to increase the expression and phosphorylation of peroxisome proliferatoractivated receptor gamma coactivator1 alpha (PGC1α).
PGC1α acts as a master metabolic regulator of energy metabolism and mitochondrial biogenesis by controlling the expression of nuclear respiratory factor (NRF) and its downstream target, mitochondrial transcription factor A (TFAM).
In adipocytes, arginine was shown to increase mitochondrial content under ambient conditions, and intensify coldinduced adipocyte browning.
Despite the heightened interest in nitrate consumption, findings about the affects of beetroot (甜菜 tián cài; BR) supplementation have been inconsistent.
The primary aim of this work is to characterize the effects a commercially available BR supplement beverage on metabolism and related metabolic gene expression in skeletal muscle.
Materials and methods

Cell culture
Murine myocytes (C2C12) were purchased from the American Type Culture Collection (Manassas, VA, USA) and cultured in Dulbecco's modified Eagle's medium containing 4500 mg/L glucose and supplemented with 10% heatinactivated fetal bovine serum and 100 U/mL penicillin/streptomycin, in a humidified 5% CO atmosphere at 37 °C (standard conditions). Following overnight seeding, cells were treated with various concentrations of the nitratecontaining commercially available BEET IT ProElite Shot from James White Drinks Ltd (Ipswich, UK) for 24 hours (ingredients are displayed in Table 1 ).
Determination of BEETIT nitrate and nitrite content
BEET IT ProElite's nitrate/nitrite content was quantified using the nitrate/nitrite quantification assay kit from Cayman Chemical (Ann Arbor, MI, USA). Nitrate and nitrite were quantified according to the manufacturer's protocol. Briefly, nitrate was quantified by diluting samples in an assay buffer, followed by 1 hour of incubation at room temperature with nitrate reductase and vitamin cofactors. Griess reagents were then added in equivocal volume to each well and incubated for 10 min at room temperature, and then sample absorbance was measured at 540 nm. The beverage nitrate concentrations were 5.312 ± 0.306μM, with undetectable nitrite. All treatments were standardized to determined nitrate concentrations of 20, 10, and 5μM, which correspond with 0.5%, 0.25%, and 0.125% BR, respectively, by volume (determined during preliminary cell viability and mitochondrial staining studies).
Metabolic assay
Cells were seeded overnight in 24well culture plate from SeaHorse Bioscience (Billerica, MA, USA) at a density of 5 × 10 cells/well, and treated with either control medium or media containing BR in dilutions corresponding with 0.5%, 0.25%, and 0.125% BR by volume for 24 hours. Following treatment, culture media was removed and replaced with XF Assay Media from SeaHorse Bioscience containing 4500 mg/L glucose free of CO and briefly incubated at 37 °C. As per the manufacturer's protocol, SeaHorse injection ports were loaded with oligomycin, an inhibitor of ATP synthase that induces maximal glycolytic metabolism and reveals endogenous proton leak (mitochondrial uncoupling) at a final concentration of 1.0 μM. Oligomycin addition was followed by the addition of carbonyl cyanide p[trifluoromethoxy]phenyl hydrazone, an uncoupler of electron transport that induces peak oxygen consumption (an indirect indicator of peak oxidative metabolism) at final concentration of 1.25μM. Rotenone was then added in 1.0μM final concentration to reveal nonmitochondrial respiration and end the metabolic reactions. Extracellular acidification, an indirect measure of glycolytic capacity, and oxygen consumption, a measure of oxidative metabolism, was measured using the SeaHorse XF24 Extracellular Analyzer from SeaHorse Bioscience. SeaHorse XF24 Extracellular Analyzer was run using 8minute cyclic protocol commands (mix for 3 minutes, let stand for 2 minutes, and measure for 3 minutes) in triplicate as previously described.
Quantitative realtime polymerase chain reaction
Following a 24hour treatment with either the control medium or media containing BR in dilutions corresponding with 0.5%, 0.25%, and 0.125% BR by volume for various durations up to 24 hours, total RNA was extracted using the RNeasy Kit from Qiagen (Valencia, CA, USA) and cDNA was synthesized using the Retroscript RT kit from Ambion (Austin, TX, USA) according to manufacturer's instructions. Polymerase chain reaction (PCR) primers were designed using the Primer Express software from Invitrogen (Carlsbad, CA, USA) and synthesized by Integrated DNA Technologies (Coralville, IA, USA). Amplifications of PGC1α, NRF1, TFAM, glucose transporter 4 (GLUT4), and mitochondrial uncoupling protein 3 (UCP3) were normalized to the housekeeping gene, TATA binding protein (TBP). Table 2 summarizes the forward and reverse primers of each gene. Quantitative reverse transcription polymerase chain reactions were performed in triplicate using the LightCycler 480 realtime PCR system from Roche Applied Science (Indianapolis, IN, USA). SYBR Green based PCR was performed in triplicate with final primer concentrations at 10μM in a total volume of 30 μL. The following cycling parameters were used: 95°C for 10 minutes followed by 45 cycles of 95°C for 15 seconds, and 60°C for 1 minute. Relative expression levels were determined using the ΔΔC method and compared to the lowest expressing group as previously described. Cells were seeded in sixwell plates at a density of 1.0 × 10 cells/well and treated with either control medium or media containing BR in dilutions corresponding with 0.5%, 0.25%, and 0.125% BR by volume for 24 hours. Following incubation, the medium was removed and the cells were resuspended in prewarmed media with 200nM Mitotracker Green from Life Technologies (Carlsbad, CA, USA) and incubated for 45 minutes in a humidified 5% CO atmosphere at 37°C. The cells were pelleted, the media with Mitotracker was removed, and the cells were suspended in prewarmed media. Group mean fluorescence was measured using Facscalibur filtering 488 nm.
Flow cytometry
Immunofluorescence and confocal microscopy
To investigate the protein expression of metabolic proteins PGC1α, cytochrome C (Cyt C), GLUT4, and UCP3, cells were seeded in chamber slides obtained from BD Bioscience (Sparks, MD, USA) with 5000 cells/well and treated with the media containing 0.5% BR by volume for 24 hours. Cells were fixed using 3.7% formaldehyde in media, permeabilized with phosphatebuffered saline (PBS) with 0.1% Triton 100X from Sigma (St. Louis, MO, USA) for 10 minutes, and blocked for 1 hour with PBS with 0.1% Triton 100X and 3.0% bovine serum albumin (BSA) purchased from Sigma. Cells were stained with either an antiPGC 1α, antiCyt C from Santa Cruz Biotechnologies (Santa Cruz, CA, USA), or an antiGLUT4 or antiUCP3 primary polyclonalantibody from Abcam (Cambridge, MA, USA) at 1:200 dilution in PBS with 0.1% BSA overnight. The cells were rinsed with PBS with 0.1% Triton 100X and 3.0% BSA, and secondary AlexFluor 488 or AlexFluor 633 from Invitrogen was applied at 1:200 dilution for 2 hours. Slides were mounted with Prolong Gold with DAPI from Invitrogen, cured overnight, and imaged using the Axiovert 25 microscope with AxioCam MRc from Zeiss (Thornwood, NY, USA).
Immunoblotting and protein expression
Cells were treated with and without media containing 0.5% BR by volume for 24 hours. Wholecell lysates were prepared by harvesting the cells on ice in high salt lysis buffer (25mM Tris base, 8mM MgCl , 1mM dithiothreitol, 15% glycerol, 0.1% Triton 100X) supplemented with protease inhibitor mix (Sigma), followed by incubation on ice for 60 minutes. The insoluble material was removed via centrifugation at 17,500 × g for 3 minutes, and protein concentrations were determined using Bradford assay (Protein Assay Dye Reagent Concentrate; BioRad Laboratories, Hercules, CA, USA). Total protein (40 μg per sample) was size separated by 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis and electrotransferred to nitrocellulose membranes. After blocking in TBST-5% nonfat milk powder for 1 hour, membranes were probed at 4°C for 24 h with an antiPGC1α or antiAMPK primary polyclonal antibody from Santa Cruz Biotechnologies, and an antiβactin primary monoclonal antibody from Sigma in TBST-1% nonfat milk powder overnight. Bound antibodies were detected by horseradish peroxidaseconjugated secondary antibodies from Sigma and by chemiluminescence using the ECL Plus Western Blotting Detection kit from GE Healthcare Life Sciences (Little Chalfont, Buckinghamshire, UK). Signal intensities were obtained by densitometry using the ImageJ software (available from the NIH at http://rsbweb.nih.gov/ij/) by quantifying lane intensities followed by normalizing intensity with corresponding βactin expression.
Cell viability
Cells were seeded in 96well plates at a density of 5000 cells/well and grown overnight. Cells were treated and incubated with either control medium or media with BR ranging from 0.0025% to 25% by volume for 24 h hours. The medium and treatment were removed, and media containing 10% WST1 was added to each well and incubated. Fluorescence was measured 1 hour following WST1 addition using Wallac Victor3V 1420 Multilabel Counter from PerkinElmer (Waltham, MA, USA).
Statistical analyses
Metabolic measurements, flow cytometry, and cell viability data were analyzed using analysis of variance with Dunnett's pairwise comparisons. Gene expression was quantified by relative expression using the ΔΔC method, and analyzed using analysis of variance with Dunnett's pairwise comparisons. Confocal microscopy images (performed using 3 randomly selected images), and Western blots were assessed for cellular fluorescence determined by image J quantification and analyzed using Student t tests. All data are presented as average ± standard deviation normalized to the control mean (control = 100) with *, **, and *** indicating p < 0.05, p < 0.01, and p < 0.001 statistical differences compared to control, respectively.
Results
BR enhances myocyte metabolism
To investigate the effects of BR on myocyte metabolism, we first measured oxygen consumption rate (OCR) following treatment with and without BR in dilutions corresponding with 0.5%, 0.25%, and 0.125% BR by volume for 24 hours. Basal OCR was significantly elevated above control levels in cells treated with BR at all tested volumes, with 0.25% BR yielding the greatest increase in basal oxidative metabolism (Fig. 1A) . Despite the significant elevations in basal oxygen consumption, BRtreated cells exhibited no change in chemically induced peak oxidative metabolism (Fig. 1B) , or mitochondrial proton leak (uncoupling) (Fig. 1  C) . To further investigate the effects of BR supplementation on myocyte metabolism, we measured the extracellular acidification rate (ECAR), an indirect measure of glycolytic metabolism. Cells treated with 0.5% or 0.25% BR exhibited significantly reduced basal and peak glycolytic metabolism compared with control cells (Fig. 1D and E) . To determine the effect of BR treatment on relative metabolic reliance, we compared the OCR/ECAR ratio of BRtreated cells to control cells. Cells treated with BR consistently displayed a significantly increased reliance on oxidative metabolism compared with control cells (Fig. 1F) . Taken together, these data suggest that cells treated with BR and grown in highglucose media develop a greater propensity to completely oxidize glucose, leading to increased oxygen consumption with concurrent reduction in lactate export (acidification).
BR induces metabolic gene expression
To investigate the effects of BR on metabolic gene expression, we treated cells with various percentages of BR for various durations and assessed the expression of PGC1α, NRF1, TFAM, GLUT4, and UCP3, which were normalized to the housekeeping gene, TBP. Treatment of myocytes with 0.5% BR by volume induced PGC1α and GLUT4 expression in a timedependent manner compared with the corresponding control. TFAM expression increased 8 hours after treatment, prior to returning to basal levels at 24 hours after treatment ( Fig. 2A) . Interestingly, NRF1 expression was unaltered at all tested time points ( Fig. 2A) . Additionally, treatment with 0.5%, 0.25%, and 0.125% BR increased PGC1α and GLUT4 expression following a 24hour treatment (Fig. 2B) . Furthermore, treatment with 0.25% and 0.125% BR increased TFAM expression, whereas only 0.25% BR increased NRF1 expression (Fig. 2B) . Mitochondrial UCP3 expression was not altered by BR treatment at any of the tested doses or durations (data not shown). Similar to gene expression, PGC1α protein expression was significantly elevated following BR treatment, which led to increased Cyt C content, an indirect indicator of increased mitochondrial content (Fig. 3A) . Moreover, while UCP3 RNA expression was unchanged in BRtreated cells, UCP3 protein expression was significantly reduced in cells treated with BR (Fig. 3A) . Also similar to RNA expression, GLUT4 expression was induced more than 2fold greater than control cells (Fig. 3A) . Additionally PGC1α and AMPK protein expression were also significantly elevated in BRtreated cells (Fig. 3B) . BR activation of metabolic gene expression also resulted in a dosedependent increase in myocyte mitochondrial content (  Fig. 3C) . Following a 24hour treatment, only treatment with 0.5% BR significantly increased mitochondrial content above control levels. In addition, cell viability was only significantly reduced in C2C12 myocytes following treatment with 2.5% BR and greater (Fig. 3D ).
Discussion
Our observations are among the first to demonstrate that a BR supplement beverage can stimulate myocyte metabolism in a favorable fashion by increasing mitochondrial biogenesis and oxidative metabolism in a PGC1αspecific fashion. Because our experiments were conducted under high glucose conditions, increased oxygen consumption with concurrent reductions in glycolytic acidification suggest that BRtreated myocytes undergo a more complete carbohydrate oxidation. Additionally, our data also demonstrate that BR can also promote GLUT4 expression, (and although speculative) nitratetreated myocytes may have enhanced glucose transport and possibly insulin sensitivity in high glucose (diabetic) conditions (observations that should be verified experimentally in vivo). Our observations also demonstrate that BR containing nitrate increases myocyte mitochondrial efficiency in a dosedependent manner, which is ultimately accompanied by an increase in total mitochondrial content; specifically increased basal mitochondrial metabolism without increased mitochondrial density following supplementation with 0.25% and 0.125% BR by volume. Similarly, previous observations by Larsen et al showed that inorganic dietary nitrate consumption in male human volunteers led to enhanced mitochondrial efficiency with suppressed UCP3 content in biopsied muscle. Despite reductions in UCP3 content, isolated mitochondria also displayed unaltered mitochondrial coupling indicated by oxygen consumption. Surprisingly, Larsen also reported no change in isolated mitochondrial oxygen consumption. Additionally, Larsen et al reported no change in PGC1α or TFAM RNA content or mitochondrial content. Moreover and contrary to our findings, Larsen et al previously found that treatment of primary myotubes with sodium nitrate decreased oxygen consumption. Perhaps most interesting, sodium nitrate consumption reduced resting energy expenditure in healthy individuals. This is a meaningful finding because it suggests that despite some potentially favorable metabolic adaptations induced by nitratecontaining foods, dietary nitrate consumption (BR) may prove counterproductive to those with existing metabolic disease such as obesity.
Despite some similarities, Larsen et al's investigation used isolated mitochondria from primary myocytes, which may account for some of the discrepancies between the two findings. Moreover, Larsen and colleagues used inorganic nitrate consumed orally, likely explaining some of the other discrepancies between our findings. Previous in vitro experiments with dietary NO precursors demonstrate that NO increases AMPK activation, leading to heightened expression of PGC1α, and potentially mitochondrial content. On a related note, Mo et al previously demonstrated that treatment of primary rat aortic smooth muscle cells with 50μM nitrate mediates mitochondrial biogenesis via the activation of sirtuin 1 and PGC1α by AMPK phosphorylation. Discrepancies between our observations and those made by Mo and colleagues may be a function of different experimental models or differences in nitrate type/source. One possible explanation for this difference may be related to nitrate bioactivation and subsequent bioavailability (considered biologically inert). Given that our experimental approach lacked commensal bacteria (microbes that express nitrate reductases catalyzing the conversation of the nitrate anion to nitrite), it is possible that an alternative mechanism exists that promotes nitratetonitrite conversion of BR extract. Jansson et al reported that in vitro mammalian tissues (gastrointestinal, liver, kidney, heart, and lung) have nitrate reductase activities, notably higher in rodents. Using allopurinol (inhibitor of xanthine oxidoreductase), the group further documented reduced conversation of nitrate to nitrite, indicating a potential reduction mechanism in vitro. Another limitation of our experimental approach is that the BR used in our study was a blend of numerous other dietary food chemicals or properties (in addition to nitrate), any of which may have contributed to our findings. Despite this limitation, our observations document that BR reproducibly increases mitochondrial content and oxygen consumption in cultured myocytes.
Conclusion
Nitratecontaining supplements are rapidly becoming a topic of interest for many athletes, especially competitive endurance athletes. Our data support the hypothesis that BR (containing nitrate) consumption may promote a favorable metabolic phenotype in skeletal muscle cells, although the observations should be verified experimentally in vivo.
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